Cigna and Spravato™ (Esketamine) - Is it covered?
Does Cigna cover Spravato™ (Esketamine)?
Cigna may cover Spravato, but approval depends on your specific health plan, diagnosis, and documented treatment history. At Libertas Mind, we help patients navigate the prior authorization process and are often successful in securing coverage so treatment can begin without delays. Cigna follows a clear set of medical-necessity requirements that must be met before Spravato is approved.
This typically includes confirming the diagnosis, reviewing past treatment attempts, and ensuring Spravato will be administered safely in a certified REMS facility. Our care team guides you through each step so the process is smooth and easy to understand.
Cigna’s Clinical Requirements for Spravato™ (Esketamine) Coverage
- Age Requirement:
- You must be 18 years or older to receive Spravato under Cigna coverage.
- Diagnosis Requirement — at least one of the following:
- Treatment-Resistant Depression (TRD) –
Cigna generally requires documentation that the patient has not responded adequately to two or more antidepressants, each from different classes. - Major Depressive Disorder (MDD) –
With acute suicidal ideation or behavior, evaluated by a qualified mental health professional.
- Additional Requirements — all of the following must be met:
Depression must be documented using a validated assessment tool such as the PHQ-9
Spravato must be used together with an oral antidepressant
Medication must be administered in a certified healthcare setting with medical supervision
Blood pressure monitoring is required before and after each dose
A minimum two-hour observation period must be performed to monitor for sedation and dissociation
Patient, prescriber, and facility must be enrolled in the REMS (Risk Evaluation and Mitigation Strategy) program
The prescriber must monitor for clinical worsening, behavioral changes, and suicidal thoughts or behaviors
These requirements help ensure safe administration and appropriate use of Spravato.
How to Check Cigna Spravato™ (Esketamine) Coverage
Libertas Mind is in-network with many major insurers, including Cigna.
Our care coordinators can:
- Verify your specific Cigna benefits
- Determine whether prior authorization is required
- Help gather documentation for eligibility
- Estimate your out-of-pocket costs
- Guide you through each step of the approval process
We make the insurance process straightforward so you can focus on your treatment.
REMS Certification and Safety Requirements
Spravato treatment is regulated by the FDA under the REMS program to ensure safe use.
This requires:
A certified healthcare facility
Trained and authorized prescribers
Patient observation for at least two hours
Documented monitoring of vital signs and side effects
Libertas Mind is a REMS-certified facility and provides a safe, structured environment for Spravato administration.
Why Spravato™ (Esketamine) Is Important for Depression Treatment
Spravato offers a valuable treatment option for adults with severe depression who haven’t found relief with traditional medications. Studies show that Spravato can produce significant improvement in depressive symptoms, especially in TRD, with 40–60% efficacy rates depending on treatment duration.
Spravato is a nasal-spray medication derived from ketamine, a compound that has been used for many years to help treat mood disorders. Unlike oral antidepressants, Spravato provides a more rapid therapeutic effect, making it an important option for individuals with severe or persistent depression.
Spravato must be administered in-office only, under medical supervision, due to safety requirements and REMS program regulations.
Libertas Mind Accepts Cigna Insurance
At Libertas Mind, we believe quality mental health care should be accessible. We accept Cigna and many other major insurance plans, and we help patients understand how their coverage applies to Spravato treatment.
Our team can guide you through verifying your Cigna benefits, understanding your Spravato coverage, and starting treatment with confidence.
Libertas Mind Accepts Cigna Insurance
At Libertas Mind, we believe quality mental health care should be accessible. We accept Cigna and many other major insurance plans, and we help patients understand how their coverage applies to Spravato treatment.
Our team can guide you through verifying your Cigna benefits, understanding your Spravato coverage, and starting treatment with confidence.
Frequently Asked Questions
Does Cigna require prior authorization for Spravato?
In most cases, yes. Cigna typically requires prior authorization to confirm that the patient meets diagnostic and clinical criteria for Spravato treatment. Our care team can assist in obtaining the necessary documentation and submitting the authorization request.
What documentation does Cigna need to approve Spravato?
Cigna usually requires:
A confirmed diagnosis of TRD or MDD with acute suicidal ideation or behavior
Medical records showing inadequate response to at least two antidepressants
Recent depression assessment scores (e.g., PHQ-9)
Confirmation that treatment will occur in a REMS-certified facility.
We help gather and submit all required documents.
Will I have out-of-pocket costs with Cigna?
Out-of-pocket expenses depend on your specific Cigna plan. Some patients may have copays, deductibles, or coinsurance. After verifying your benefits, we can give you a clear estimate of your expected costs before treatment begins.
Can Spravato be taken at home if Cigna approves it?
No. Spravato cannot be self-administered at home. Cigna requires that all Spravato doses be administered in a REMS-certified healthcare setting with mandatory post-dose monitoring. This ensures patient safety and treatment compliance.
